MarketInOut Stock Screener Log In | Sign Up

Bavarian Nordic A/S

XETRA • Healthcare • Biotechnology • Quote as of 10/30/2026
Bavarian Nordic A/S stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeXETRA
Market Capitalization2,460.52 mln
Float64.56 mln
Earnings Date11/13/2026

EPS

2.62
Solid

P / E

12.62
Fair value

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-1.95
Caution advised

Relative Strength

80 / 100
Strongly outperforming

Debt / Equity

0.01
Debt-free

Business Description

Founded in 1992 and based in Hellerup, Denmark, Bavarian Nordic is a vaccine company that protects people against a range of serious infectious diseases. Its products include vaccines for smallpox, monkeypox, rabies, tick-borne encephalitis, cholera, and typhoid fever, sold under well-known brand names across the United States, Europe, Asia, and beyond. The company is also running clinical trials on a new vaccine aimed at combating dangerous encephalitis viruses.

Key Fundamentals

EPS2.62
P/E12.62
ROE12.05
ROIC7.29
ROA10.59
Interest Cover66.23
EBITDA, mln365
EV / EBITDA6.18
EV / EBIT8.45
Revenue, mln838
EV / Revenue2.70

Quote Details

Last 33.06
Change -0.5 (-1.49%)
Open 33.34
Volume 13
Turnover 429.78
Average Volume 322

Financial Ratios

Pre-Tax Profit Margin32
Current Ratio6.53
Price / Book1.47
Price / Tangible Book2.62
Price / Free Cash Flow16.21
Debt / Equity0.01
Price / Sales3.17

Financial Strength

Altman Z-Score10.1
Piotroski F-Score 6 / 9
Beneish M-Score-1.95
Price to Intrinsic Value0.98
Price to Graham Number1.24
Shiller PE Ratio55.35

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.66% 73 / 100   
1 Month 13.37% 93 / 100   
2 Months 36.27% 98 / 100   
6 Months 32.66% 95 / 100   
1 Year 5.69% 42 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog